Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-06 Sale | 2023-01-10 7:19 pm | Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer | 2,403 | $36.3 | $87,225 | 214,355 (Direct) | View |
| 2022-01-06 Purchase | 2022-01-10 8:30 pm | Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer | 6,842 | $19 | $129,998 | 344,258 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-27 Exercise | 2023-12-29 4:07 pm | N/A 2029-05-13 | Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer | 25,000 | $0 | 320,685 (Direct) | View |
| 2023-12-27 Exercise | 2023-12-29 4:07 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer | 25,000 | $0.37 | 320,685 (Direct) | View |
| 2023-07-12 Exercise | 2023-07-14 4:20 pm | N/A 2029-05-13 | Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer | 20,000 | $0 | 320,685 (Direct) | View |
| 2023-07-12 Exercise | 2023-07-14 4:20 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer | 20,000 | $0.37 | 320,685 (Direct) | View |
| 2023-05-22 Gift | 2023-05-24 4:38 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer | 1,580 | $0 | 231,108 (Direct) | View |
| 2023-03-16 Option Award | 2023-03-20 8:27 pm | N/A 2033-03-16 | Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer | 100,833 | $0 | 315,188 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-10 8:30 pm | N/A 2032-01-06 | Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer | 155,833 | $0 | 344,258 (Direct) | View |
Ownership | 2022-01-06 5:07 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer | 0 | $0 | 336,160 (Direct) | View |